...
search icon
teva-img

Teva Pharma Industries Ltd ADR Share Price

TEVA
NYQ
$32.125
+$0.32
(1.01%)
1D
Industry: Pharmaceuticals Sector: Health Care

Teva Pharma Industries Ltd ADR Analyst Forecast

Teva Pharma Industries Ltd ADR Share Price Chart

Teva Pharma Industries Ltd ADR Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$36.50B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
51.9016
Volume info-icon
This is the total number of shares traded during the most recent trading day.
12.09M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.66
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$12.47 L
$33.42 H
$32.125

About Teva Pharma Industries Ltd ADR, Common Stock

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders " chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. more

Industry: PharmaceuticalsSector: Health Care

Teva Pharma Industries Ltd ADR Stock Returns

Time FrameTEVASectorS&P500
1-Week Return2.49%1.34%1.71%
1-Month Return0.78%0.92%-0.16%
3-Month Return63.9%7.59%0.61%
6-Month Return94.67%16.4%8.27%
1-Year Return47.57%6.73%14.98%
3-Year Return212.95%17.72%70.47%
5-Year Return160.88%33.55%79.66%
10-Year Return-49.83%132.51%263.43%

Teva Pharma Industries Ltd ADR Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue16.66B15.88B14.93B15.85B16.54B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":95.31,"profit":true},{"date":"2022-12-31","value":89.59,"profit":true},{"date":"2023-12-31","value":95.12,"profit":true},{"date":"2024-12-31","value":99.31,"profit":true}]
Cost of Revenue8.93B8.28B7.95B8.20B8.48B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":92.73,"profit":true},{"date":"2022-12-31","value":89.02,"profit":true},{"date":"2023-12-31","value":91.81,"profit":true},{"date":"2024-12-31","value":94.94,"profit":true}]
Gross Profit7.73B7.59B6.97B7.64B8.06B[{"date":"2020-12-31","value":95.82,"profit":true},{"date":"2021-12-31","value":94.18,"profit":true},{"date":"2022-12-31","value":86.48,"profit":true},{"date":"2023-12-31","value":94.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin46.38%47.83%46.72%48.25%48.74%[{"date":"2020-12-31","value":95.16,"profit":true},{"date":"2021-12-31","value":98.13,"profit":true},{"date":"2022-12-31","value":95.86,"profit":true},{"date":"2023-12-31","value":98.99,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses11.30B5.88B9.17B4.45B8.37B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.03,"profit":true},{"date":"2022-12-31","value":81.16,"profit":true},{"date":"2023-12-31","value":39.4,"profit":true},{"date":"2024-12-31","value":74.05,"profit":true}]
Operating Income(3.57B)1.72B(2.20B)433.00M(303.00M)[{"date":"2020-12-31","value":-208.16,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-128.03,"profit":false},{"date":"2023-12-31","value":25.23,"profit":true},{"date":"2024-12-31","value":-17.66,"profit":false}]
Total Non-Operating Income/Expense(1.32B)(2.01B)(1.91B)(2.15B)(2.03B)[{"date":"2020-12-31","value":-132200000100,"profit":false},{"date":"2021-12-31","value":-201100000000,"profit":false},{"date":"2022-12-31","value":-191100000000,"profit":false},{"date":"2023-12-31","value":-215200000000,"profit":false},{"date":"2024-12-31","value":-203000000000,"profit":false}]
Pre-Tax Income(3.93B)667.00M(3.14B)(624.00M)(1.28B)[{"date":"2020-12-31","value":-589.36,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-471.06,"profit":false},{"date":"2023-12-31","value":-93.55,"profit":false},{"date":"2024-12-31","value":-192.35,"profit":false}]
Income Taxes168.00M211.00M(643.00M)(65.00M)676.00M[{"date":"2020-12-31","value":24.85,"profit":true},{"date":"2021-12-31","value":31.21,"profit":true},{"date":"2022-12-31","value":-95.12,"profit":false},{"date":"2023-12-31","value":-9.62,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(4.10B)456.00M(2.50B)(559.00M)(1.96B)[{"date":"2020-12-31","value":-898.9,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-548.03,"profit":false},{"date":"2023-12-31","value":-122.59,"profit":false},{"date":"2024-12-31","value":-429.61,"profit":false}]
Income From Continuous Operations(4.24B)447.00M(2.41B)(615.00M)(1.96B)[{"date":"2020-12-31","value":-948.1,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-538.26,"profit":false},{"date":"2023-12-31","value":-137.58,"profit":false},{"date":"2024-12-31","value":-438.26,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(3.99B)417.00M(2.45B)(559.00M)(1.64B)[{"date":"2020-12-31","value":-956.83,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-586.57,"profit":false},{"date":"2023-12-31","value":-134.05,"profit":false},{"date":"2024-12-31","value":-393.05,"profit":false}]
EPS (Diluted)2.572.582.532.561.41[{"date":"2020-12-31","value":99.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.06,"profit":true},{"date":"2023-12-31","value":99.22,"profit":true},{"date":"2024-12-31","value":54.65,"profit":true}]

Teva Pharma Industries Ltd ADR Ratios

Teva Pharma Industries Ltd ADR Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

TEVA
Cash Ratio 0.19
Current Ratio 1.11
Quick Ratio 0.82

Teva Pharma Industries Ltd ADR Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TEVA
ROA (LTM) 5.49%
ROE (LTM) 9.71%

Teva Pharma Industries Ltd ADR Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TEVA
Debt Ratio Lower is generally better. Negative is bad. 0.82
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.18

Teva Pharma Industries Ltd ADR Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TEVA
Trailing PE 51.90
Forward PE 11.06
P/S (TTM) 2.17
P/B 4.97
Price/FCF 156
EV/R 3.05
EV/Ebitda 17.99
PEG 1.29

FAQs

What is Teva Pharma Industries Ltd ADR share price today?

Teva Pharma Industries Ltd ADR (TEVA) share price today is $32.125

Can Indians buy Teva Pharma Industries Ltd ADR shares?

Yes, Indians can buy shares of Teva Pharma Industries Ltd ADR (TEVA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TEVA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Teva Pharma Industries Ltd ADR be purchased?

Yes, you can purchase fractional shares of Teva Pharma Industries Ltd ADR (TEVA) via the Vested app. You can start investing in Teva Pharma Industries Ltd ADR (TEVA) with a minimum investment of $1.

How to invest in Teva Pharma Industries Ltd ADR shares from India?

You can invest in shares of Teva Pharma Industries Ltd ADR (TEVA) via Vested in three simple steps:

  • Click on Sign Up or Invest in TEVA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Teva Pharma Industries Ltd ADR shares
What is Teva Pharma Industries Ltd ADR 52-week high and low stock price?

The 52-week high price of Teva Pharma Industries Ltd ADR (TEVA) is $33.42. The 52-week low price of Teva Pharma Industries Ltd ADR (TEVA) is $12.47.

What is Teva Pharma Industries Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Teva Pharma Industries Ltd ADR (TEVA) is 51.9016

What is Teva Pharma Industries Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Teva Pharma Industries Ltd ADR (TEVA) is 4.97

What is Teva Pharma Industries Ltd ADR dividend yield?

The dividend yield of Teva Pharma Industries Ltd ADR (TEVA) is 0.00%

What is the Market Cap of Teva Pharma Industries Ltd ADR?

The market capitalization of Teva Pharma Industries Ltd ADR (TEVA) is $36.50B

What is Teva Pharma Industries Ltd ADR's stock symbol?

The stock symbol (or ticker) of Teva Pharma Industries Ltd ADR is TEVA

How Can Investors Use Teva Pharma Industries Ltd ADR Share Price Data for Long-Term Investment Decisions?

Consider the share price of Teva Pharma Industries Ltd ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Teva Pharma Industries Ltd ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Teva Pharma Industries Ltd ADR shares for Indian investors?

When investing in Teva Pharma Industries Ltd ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Teva Pharma Industries Ltd ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Teva Pharma Industries Ltd ADR share price with other stocks in the same sector?

Rather than merely checking the share price of Teva Pharma Industries Ltd ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Teva Pharma Industries Ltd ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top